Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Times Sunshine Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise in China that specializes in the R&D, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) and modern pharmaceuticals. Originating from the Yongzhou Lingling Pharmaceutical Factory founded in 1969, the company now operates eight GMP-certified automated production lines covering oral liquids, granules, and tablets. Its product portfolio is centered on respiratory health, pediatrics, and digestive medicine, with flagship products like Houyanqing Granule and Xiaoer Fu Pi Granule serving thousands of medical institutions across China. The company distinguishes itself through its focus on the scientific analysis of complex drug mechanisms, maintaining a provincial-level key laboratory in collaboration with the China Academy of Chinese Medical Sciences. Times Sunshine is recognized as a national high-tech enterprise and a 'Little Giant' of provincial industry in Hunan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Times Sunshine Pharmaceutical.